Method and system for a hybrid control-to-target and control-to-range model predictive control of an artificial pancreas

• US 9,907,909 B2
• Filed: 12/20/2012
• Issued: 03/06/2018
• Est. Priority Date: 12/20/2012
• Status: Active Grant

• Current Assignee: JDRF International
• Original Assignee: Animas Corporation (Johnson & Johnson)
• Inventors: Finan, Daniel, McCann, Thomas
• Primary Examiner(s): Sirmons, Kevin C
• Assistant Examiner(s): Legette-Thompson, Tiffany
• Application Number:
  US13/722,329
• Publication Number:
  US 20140180240A1
• Time in Patent Office: 1,902 Days
• Field of Search: 604 66, 604504, 604506, 706 52
• CPC Class Codes: A61M 2205/3576 with non implanted data transmission devices, e.g. using external transmitter or receiver
• CPC Class Codes: A61M 5/14244 adapted to be carried by the patient, e.g. portable on the body
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00
• CPC Class Codes: G16H 20/17 delivered via infusion or injection
• CPC Class Codes: G16H 50/50 for simulation or modelling of medical disorders

Abstract

Described and illustrated is a system for management of diabetes that includes an infusion pump, glucose sensor and controller with a method programmed into the controller. The infusion pump is configured to deliver insulin to a subject. The glucose sensor is configured to sense glucose levels in the subject and provide output signals representative of the glucose levels in the subject. The controller is programmed to switchover from one mode of MPC control based on a predetermined range of blood glucose values to another MPC mode based on a predetermined target.

Claims

1. A method to control a glucose management system having an infusion pump with a model-predictive-controller that receives data from at least one glucose sensor and which the model-predictive controller has a control-to-target operating mode in which the model-predictive controller is configured to maintain glucose at a specific target value and a control-to-range operating mode in which the model-predictive controller is configured to maintain glucose within a target range of values, the method comprising:

initially engaging the model-predictive controller in the control-to-range operating mode;

measuring glucose level in the subject from the at least one glucose sensor to provide at least one glucose measurement in each time interval in a series of discrete time interval index;

using the model-predictive controller in the control-to-range operating mode to predict at least one future glucose value based on the glucose measurements made in the measuring step;

using the model-predictive controller to evaluate whether the at least one future glucose value is within the target range of glucose values for the control-to-range operating mode;

configuring the model-predictive controller based on evaluation of the at least one predicted future glucose value to;

(i) maintain the model-predictive controller in the control-to-range operating mode if the at least one predicted future glucose value is within the target range of glucose values for the control-to-range operating mode and determining an insulin amount with the model-predictive controller using the control-to-range operating mode wherein a cost function is calculated using the model-predictive controller based on deviation of the at least one predicted future glucose value from the target range of glucose values; and

(ii) shift the model-predictive-controller from the control-to-range operating mode to the control-to-target operating mode and determining an insulin amount with the model-predictive-controller in the control-to-target operating mode when the at least one predicted future glucose value is outside the target range of glucose values wherein a cost function is calculated using the model-predictive controller based on deviation of the at least one predicted future glucose value from a specific target glucose value; and

delivering the insulin in the amount determined, wherein the cost function is defined as;

2. The method of claim 1, in which the measuring comprises assaying glucose values with a continuous glucose sensor.

3. The method of claim 1, in which the delivering comprises injecting the insulin with an insulin infusion pump.

4. The method of claim 1, in which the target range varies over time.

5. The method of claim 1, wherein, when the insulin amount is determined with the model-predictive controller using the control-to-range operating mode, when the at least one predicted glucose value falls within the target range of glucose values, there is no penalty contribution to the cost function and when the at least one predicted glucose value falls outside the target range of glucose values, there is an increasing penalty contribution to the cost function based on a weighting factor.

6. The method of claim 1, wherein, when the insulin is determined with the model-predictive-controller in the control-to-target operating mode, a penalty contribution to the cost function is equivalent to deviation from the target glucose value.

7. The method of claim 1, wherein the cost function is further defined as:

J(I_D′

)=Σ

∥

G^zone(k+j)∥

+R·

Σ

∥

I_D(k+j)−

basal(k+j)∥

.

8. The method of claim 1, wherein, in the control-to-range operating mode, G^zone is determined as:

9. The method of claim 1, wherein, in the control-to-range operating mode, G^zone is determined as:

G^zone=G^target=|G−

G_sp|,

where G_sp is the target glucose value.

10. The method of claim 1, wherein, in the control-to-range operating mode, G^zone is determined as:

G^zone=G^target=(G−

G_sp)²,

where G_sp is the target glucose value.

11. A system for management of diabetes comprising:

a continuous glucose monitor to continuously measure glucose level of the subject at discrete generally uniform time intervals and provide the glucose level at each interval in the form of glucose measurement data;

an insulin infusion pump to deliver insulin; and

a model-predictive controller in communication with the infusion pump and the continuous glucose monitor in which the model-predictive controller is configured to operate in two separate operating modes;

namely, a control-to-range operating mode in which the model-predictive controller is configured to maintain glucose within a target range of values and a control-to-target operating mode in which the model-predictive controller is configured to maintain glucose at a specific target value,

wherein the model-predictive controller is further configured to predict at least one future glucose value based on prior glucose measurement data from the continuous glucose monitor while in the control-to-range operating mode, evaluate whether the at least one future glucose value is within the target range of glucose values in which the model-predictive controller is configured to operate and control insulin amounts in each of the two operating modes based on evaluation of the at least one future glucose value,

the model-predictive controller being maintained in the control-to-range operating mode if the predicted at least one future glucose value is within the target range of values and being configured to calculate a cost function based on deviation of the at least one predicted future glucose value from the target range of glucose values and the model-predictive controller being automatically shifted to the control-to-target operating mode in which the model-predictive controller is configured to calculate a cost function based on deviation from a target glucose value if the predicted at least one future glucose value is outside of the target range of values,

wherein the model-predictive controller determines an insulin amount to be delivered depending on the operating mode and commands the insulin infusion pump to deliver the insulin amount determined by the model-predictive controller wherein calculated amounts of insulin are delivered at predetermined time intervals based on future predicted glucose values in each operating mode wherein the cost function is defined as;

12. The system of claim 11, in which the target range varies over time.

13. The method of claim 11, wherein, when the insulin amount is determined with the model-predictive controller using the control-to-range operating mode, when the at least one predicted glucose value falls within the target range of glucose values, there is no penalty contribution to the cost function and when the at least one predicted glucose value falls outside the target range of glucose values, there is an increasing penalty contribution to the cost function based on a weighting factor.

14. The method of claim 11, wherein, when the insulin is determined with the model-predictive-controller in the control-to-target operating mode, a penalty contribution to the cost function is equivalent to deviation from the target glucose value.

15. The method of claim 11, wherein the cost function is further defined as:

J(I_D′

)=Σ

∥

G^zone(k+j)∥

+R·

Σ

∥

I_D(k+j)−

basal(k+j)∥

.

16. The method of claim 11, wherein, in the control-to-range operating mode, G^zone is determined as:

17. The method of claim 11, wherein, in the control-to-range operating mode, G^zone is determined as:

G^zone=G^target=|G−

G_sp|,

where G_sp is the target glucose value.

18. The method of claim 11, wherein, in the control-to-range operating mode, G^zone is determined as:

G^zone=G^target=(G−

G_sp)²,

where G_sp is the target glucose value.